CASP2 and non-small cell lung carcinoma: Moreover, multiple miRNAs including miR-183 [69], miR-494 [70] and miR-182-5p [71] have been shown to function as tumor promoters in non-small cell lung cancer (NSCLC) by inhibiting caspase-2-induced apoptosis.